HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 204 | 250 | 81.6% | |
| HF 4 | 2012 | 224 | 274 | 81.8% | |
| HF 4 | 2013 | 245 | 274 | 89.4% | |
| HF004 | 2014 | 158 | 167 | 94.6% | |
| HF004 | 2015 | 195 | 203 | 96.1% | |
| HF004 | 2016 | 248 | 258 | 96.1% | |
| HF004 | 2017 | 299 | 312 | 95.8% | |
| HF004 | 2018 | 376 | 395 | 95.2% | |
| HF004 | 2019 | 397 | 422 | 94.1% | |
| HF004 | 2020 | 378 | 402 | 94.0% |
